Koyfin Home > Directory > Health Care > Albireo Pharma Inc > Cash and Short-Term Investments

Albireo Pharma Inc Cash and Short-Term Investments Chart (ALBO)

Albireo Pharma Inc annual/quarterly Cash and Short-Term Investments from 2015 to 2020.
  • Albireo Pharma Inc Cash and Short-Term Investments for the quarter ending June 06, 2020 was $152m a 6.15% increase of 9m year over year
  • Albireo Pharma Inc Cash and Short-Term Investments for the last 12 months ending June 06, 2020 was $152m a 6.15% increase of 9m year over year
  • Albireo Pharma Inc Annual Cash and Short-Term Investments for 2019 was $132m a -24.30% decrease of -32m from 2018
  • Albireo Pharma Inc Annual Cash and Short-Term Investments for 2018 was $164m a 67.52% increase of 111m from 2017
  • Albireo Pharma Inc Annual Cash and Short-Term Investments for 2017 was $53m a 43.77% increase of 23m from 2016
Other Balance Sheet Metrics:
  • Albireo Pharma Inc Total Assets for the quarter ending September 09, 2018 was $194m a 62.30% increase of 121m year over year
  • Albireo Pharma Inc Other Liabilities for the quarter ending December 12, 2018 was $50m a 8.86% increase of 4m year over year
  • Albireo Pharma Inc Total Equity for the quarter ending September 09, 2018 was $137m a 52.25% increase of 71m year over year
View Chart On Koyfin

Quarterly ALBO Cash and Short-Term Investments Data

06/2020$152m
03/2020$151m
12/2019$132m
09/2019$143m
06/2019$158m
03/2019$150m
12/2018$164m
09/2018$174m
06/2018$183m
03/2018$193m

Annual ALBO Cash and Short-Term Investments Data

2019$132m
2018$164m
2017$53m
2016$30m
2015$5m
2014$8m